Spyre Therapeutics Correlations

SYRE Stock

22.27 0.37 1.69%

The current 90-days correlation between Spyre Therapeutics and Wheels Up Experience is 0.2 (i.e., Modest diversification). The correlation of Spyre Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Spyre Therapeutics Correlation With Market

Modest diversification

The correlation between Spyre Therapeutics and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spyre Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Spyre Stock refer to our How to Trade Spyre Stock guide.

Moving together with Spyre Stock

0.81	JNJ	Johnson Johnson	Pair Corr
0.86	INZY	Inozyme Pharma	Pair Corr
0.7	KRYS	Krystal Biotech	Pair Corr
0.84	MREO	Mereo BioPharma Group	Pair Corr
0.88	NKTX	Nkarta Inc	Pair Corr
0.97	PDSB	PDS Biotechnology Corp	Pair Corr
0.69	PLRX	Pliant Therapeutics	Pair Corr
0.71	ABBV	AbbVie Inc Earnings Call Today	Pair Corr
0.98	ABOS	Acumen Pharmaceuticals	Pair Corr
0.89	ADAP	Adaptimmune Therapeutics	Pair Corr
0.93	AFMD	Affimed NV	Pair Corr
0.67	AGIO	Agios Pharm	Pair Corr
0.89	AMGN	Amgen Inc Earnings Call This Week	Pair Corr
0.91	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.82	APTO	Aptose Biosciences	Pair Corr
0.76	STOK	Stoke Therapeutics	Pair Corr
0.89	BDTX	Black Diamond Therap	Pair Corr
0.78	TERN	Terns Pharmaceuticals Buyout Trend	Pair Corr
0.82	CRVS	Corvus Pharmaceuticals	Pair Corr
0.94	DAWN	Day One Biopharmaceu	Pair Corr
0.88	ACET	Adicet Bio	Pair Corr
0.83	SHG	Shinhan Financial Earnings Call This Week	Pair Corr
0.63	WF	Woori Financial Group Earnings Call This Week	Pair Corr

Moving against Spyre Stock

0.64	MLAB	Mesa Laboratories Earnings Call This Week	Pair Corr
0.44	BMY	Bristol Myers Squibb Earnings Call This Week	Pair Corr
0.4	PTCT	PTC Therapeutics	Pair Corr
0.35	BPMC	Blueprint Medicines Corp Sell-off Trend	Pair Corr
0.87	FNMFO	Federal National Mortgage	Pair Corr
0.71	MNPR	Monopar Therapeutics	Pair Corr
0.64	AVAL	Grupo Aval	Pair Corr
0.48	ITCL	Banco Ita Chile	Pair Corr
0.45	CIB	Bancolombia SA ADR	Pair Corr
0.41	TGNA	Tegna Inc	Pair Corr

Related Correlations Analysis

	UBER	PVARF	CLPS	UP	DH	WB	ASLE	NOW
UBER		-0.09	0.43	0.52	0.0	-0.58	-0.47	-0.67	UBER
PVARF	-0.09		0.43	-0.71	-0.29	0.0	0.04	-0.14	PVARF
CLPS	0.43	0.43		-0.08	-0.06	-0.03	-0.23	-0.4	CLPS
UP	0.52	-0.71	-0.08		0.19	-0.21	-0.43	-0.29	UP
DH	0.0	-0.29	-0.06	0.19		0.33	0.42	0.56	DH
WB	-0.58	0.0	-0.03	-0.21	0.33		0.34	0.6	WB
ASLE	-0.47	0.04	-0.23	-0.43	0.42	0.34		0.73	ASLE
NOW	-0.67	-0.14	-0.4	-0.29	0.56	0.6	0.73		NOW
	UBER	PVARF	CLPS	UP	DH	WB	ASLE	NOW

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NOW	+ 0.73	ASLE
NOW	+ 0.6	WB
NOW	+ 0.56	DH
UP	+ 0.52	UBER
CLPS	+ 0.43	UBER
CLPS	+ 0.43	PVARF

High negative correlations

UP	- 0.71	PVARF
NOW	- 0.67	UBER
WB	- 0.58	UBER
ASLE	- 0.47	UBER
ASLE	- 0.43	UP
NOW	- 0.4	CLPS

Risk-Adjusted Indicators

There is a big difference between Spyre Stock performing well and Spyre Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Spyre Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
UBER	1.56	(0.23)	0.00	(3.08)	0.00	0.00	2.67	(5.35)	12.29
PVARF	0.28	0.08	0.00	(0.21)	0.00	0.00	0.00	0.00	7.89
CLPS	2.86	0.05	(0.02)	(0.12)	3.26	(3.97)	7.34	(5.97)	24.69
UP	3.41	(0.44)	0.00	(0.78)	0.00	0.00	6.90	(7.60)	27.26
DH	2.25	0.23	0.07	0.59	2.26	(2.93)	5.83	(4.35)	16.28
WB	2.10	0.11	0.03	0.29	2.25	(2.33)	4.62	(3.33)	11.94
ASLE	1.75	0.42	0.15	2.37	1.85	(1.89)	4.14	(2.58)	12.13
NOW	1.50	0.06	0.00	0.20	2.47	(1.48)	2.58	(2.68)	11.04

Spyre Therapeutics Corporate Management

James JD	Consultant	Profile
Janet MBA	Senior Operations	Profile
Eric McIntyre	Vice Relations	Profile
Deanna MD	Senior Development	Profile
CFE CPA	Vice Controller	Profile
Justin LaFountaine	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC